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ABSTRACT: CimH of Bacillus subtilis is a secondary transporter for citrate and malate that belongs to the
2-hydroxycarboxylate transporter (2HCT) family. Conserved residues R143, R420, and Q428, located in
putative cytoplasmic loops and R432, located at the cytoplasmic end of the C-terminal transmembrane
segment XI were mutated to Cys to identify residues involved in binding of the substrates. R143C, R420C,
and Q428C revealed kinetics similar to those of the wild-type transporter, while the activity of R432C
was reduced by at least 2 orders of magnitude. Conservative replacement of R432 with Lys reduced the
activity by 1 order of magnitude, by lowering the affinity for the substrate 10-fold. It is concluded that
the arginine residue at position 432 in CimH interacts with one of the carboxylate groups of the substrates.
Labeling of the R420C and Q428C mutants with thiol reagents inhibited citrate transport activity.
Surprisingly, the cysteine residues in the cytoplasmic loops in both R420C and Q428C were accessible
to the small, membrane-impermeable, negatively charged MTSES reagent from the external site of the
membrane in a substrate protectable manner. The membrane impermeable reagents MTSET,1 which is
positively charged, and AMdiS, which is negatively charged like MTSES but more bulky, did not inhibit
R420C and Q428C. It is suggested that the access pathway is optimized for small, negatively charged
substrates. Either the cytoplasmic loop containing residues R420 and Q428 is partly protruding to the
outside, possibly in a reentrant loop like structure, or alternatively, a water-filled substrate translocation
pathway extents to the cytoplasm-membrane interface.
The 2-hydroxycarboxylate transporter (2HCT) family
consists of transporters for L-malate and citrate, some of
which have been studied extensively. The family contains
Na+- and H+-symporters (CitS of Klebsiella pneumoniae,
MaeN and CimH of Bacillus subtilis and MaeP of Strepto-
coccus boVis (1-4)), but also citrate/lactate and malate/lactate
exchangers found in lactic acid bacteria (CitP of Leuconostoc
mesenteroides and MleP of Lactococcus lactis (5, 6)). The
latter transporters are involved in proton motive force
generation under physiological conditions (7-9). Substrate
specificity studies revealed that the symporters in the family
are very specific, transporting only citrate and malate, while
the exchangers catalyze a wide range of 2-hydroxycarboxy-
lates (5). The transporters of the 2HCT family are believed
to traverse the cytoplasmic membrane 11 times (10, 11) with
the N-terminus and the C-terminus localized inside and
outside the cell, respectively (Figure 1).
Members of the 2HCT family recognize specifically
substrates that contain the 2-hydroxycarboxylate motif
(Figure 1, inset), indicating essential interactions between
sites on the proteins and the hydroxyl and carboxylate groups
of the substrates. The difference between the symporters and
the exchangers in the family is in their tolerance toward the
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FIGURE 1: Model of the membrane topology of CimH. Boxes
indicate putative transmembrane segments. The length of the
connecting loops corresponds more or less with the numbers of
residues in the loop regions. Conserved residues within the 2HCT
family were marked with a grayed dot, the two cysteine residues
in the protein with an open dot. The inset shows the 2-hydroxy-
carboxylate motif that is common to the substrates of the family
and L-malate.
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R-enantiomers of chiral 2-hydroxycarboxylates (12). The
symporters are strictly stereoselective and accept only CH2-
COOH at RS and H (in malate) or CH2COOH (in citrate) at
RR (2, 12). In contrast, the exchangers accept groups differing
in size and charge. This allows them to translocate both
monovalent monocarboxylates (lactate) and divalent di/
tricarboxylates (malate/citrate), which is essential for their
physiological function of generating membrane potential. The
high tolerance of the exchangers to the R groups of the
substrates has allowed the identification of the C-terminal
transmembrane segment XI (TMS XI) and the preceding
cytoplasmic loop, a region that is particularly well conserved
in the family, as part of the substrate binding site by
analyzing chimeric transport proteins (13). More particularly,
R425 (CitP numbering) located at the cytoplasmic side of
TMS XI was shown to interact directly with the carboxylate
at the RS position resulting in high-affinity binding of di/
tricarboxylates (14). The essential interactions of the proteins
with the hydroxyl and carboxylate of the 2-hydroxycarboxy-
late motif of the substrates have not been identified. These
interactions are likely to be mediated by residues that are
conserved within all members of the 2HCT family.
We have previously described the cloning and character-
ization of CimH in the 2HCT family encoded by the ORF
designated yxkJ in the B. subtilis genome-sequencing project
(2, 15). CimH is a symporter that transports citrate and
L-malate, while it binds but does not transport L-citramalate.
Therefore, CimH recognizes 2-hydroxycarboxylates with a
carboxylate at the RS position, suggesting, in addition to
essential interactions with the 2HCT motif, an essential role
for R432 (the equivalent of R425 of CitP) in substrate
recognition and transport. We set out to identify residues
involved in the essential interactions with the substrates of
CimH. Besides R432, the conserved residues R143 located
at the cytoplasmic end of TMS IV (see Figure 1), Q428
located one turn of a helix away from R432, and R420
located in the conserved cytoplasmic loop preceding TMS
XI were selected for mutagenesis. R432 is shown to play a
similar role as R425 in CitP, but surprisingly, conserved
residues R143, R420, and Q428 could be mutated to cysteine
without loss of activity and, therefore, are not directly
involved in the transport mechanism. Nevertheless, labeling
of R420C and Q428C, but not of R143C, with thiol reactive
reagents inhibited citrate transport activity. Surprisingly,
R420C, Q428C, and also R432C were accessible from the
periplasmic site of the membrane by membrane the imper-
meable thiol reactive reagent MTSES. The data suggest that
either the conserved part of the cytoplasmic loop in front of
TMS XI containing R420 and Q428 is either partly protrud-
ing to the outside, possibly in a reentrant loop like structure,
or alternatively, a water filled substrate translocation pathway
extents all the way down to the substrate binding site located
at the cytoplasm-membrane interface.
EXPERIMENTAL PROCEDURES
Strains and Growth Conditions. Escherichia coli strain
Top10 harboring the expression plasmid pETCimH that
contains the gene coding for CimH with a N-terminal His6
tag (2) was routinely grown in flasks in Luria Bertani Broth
(LB) at 37 °C under continuous shaking at 150 rpm.
Ampicillin was added at a final concentration of 50 íg/mL.
Expression of CimH was induced for 1.5 h by adding 100
íM isopropylthiogalactopyranoside (IPTG) when the optical
density measured at 660 nm (OD660) of the culture was 0.6.
The cell culture was cooled on ice and harvested by
centrifugation at 10 000g for 10 min.
Construction of Site-Directed Mutants of CimH. Site-
directed mutants of CimH were prepared by a two-step PCR
method using Pwo DNA polymerase for high-fidelity
amplification (Roche Molecular Biochemicals, Mannheim,
Germany). Overlapping primers containing the desired
mutation were used to prepare short PCR fragments with
either pETCimH or pETC-less as template DNA. These PCR
fragments were purified from an agarose gel using the Qiagen
gel extraction kit according to the manufacturer protocol,
and used as primer in the second PCR step. The final PCR
products of the expected size (1300 bp) were purified from
gel and digested with NcoI and XbaI, ligated into pET302
digested with the same enzymes, and subsequently trans-
formed to E. coli DH5R. Transformants were selected for
ampicillin resistance on LB agar plates. All mutants were
sequenced (Baseclear, Leiden The Netherlands) to confirm
the presence of the desired and absence of any undesired
mutations.
Preparation of Membrane Vesicles. Right-side-out mem-
brane vesicles (RSO) were prepared by the osmotic lysis
procedure, as described previously (16). The membranes
were resuspended in 50 mM potassium phosphate (KPi), pH
6.1.
Inside-out (ISO) membrane vesicles were prepared by
washing the cells once with 10 mM Tris-HCl pH 8 buffer,
followed by suspension in a small volume of 50 mM KPi,
pH 7. Subsequently, the cell suspension was passed twice
through a French Pressure Cell operated at 13 kpsi. Cell
debris and whole cells were removed by a low spin at 8000
rpm for 10 min at 4°C in a Beckman SS34 rotor. Membranes
were collected by ultracentrifugation for 20 min at 80 000
rpm at 4°C in a Beckman TLA 100.4 rotor. After washing
once with 50 mM KPi, pH 7, the membranes were resus-
pended in the same buffer.
RSO and ISO membrane vesicles were rapidly frozen in
liquid nitrogen and stored at -80 °C. Membrane protein was
determined using the DC Protein Assay Kit (Bio-Rad
Laboratories, USA).
Partial Purification Using Ni-NTA Affinity Chromatog-
raphy. ISO membranes were solubilized by 4-fold dilution
in 50 mM KPi pH 8 buffer containing 10% glycerol, 1%
aminoxid, 100 mM NaCl, and 10 mM imidazol, pH 8. The
suspension was stirred gently for 30 min while one ice.
Nonsolubilized particles were removed by centrifugation at
4 °C for 5 min in an Eppendorf Tabletop centrifuge operated
at 13 000 rpm. Ni-NTA columns were prepared according
to the manufacturer’s instructions. CimH was allowed to bind
f o r1ha t4°C, after which the column was washed once
with 5 column volumes of solubilization buffer containing
0.1% aminoxid and once with 10 column volumes containing
0.1% aminoxid and 20 mM imidazol. The protein was eluted
by incubating the resin for 30 min at 4 °C with 2 volumes
of the same buffer at pH 7 and containing 200 mM imidazol.
The protein was stored at -20 °C. Purification of all mutants
was equally successful as observed for the wild-type CimH.
In all cases the protein running at a molecular weight of 48
kDa was the most abundant protein band on a silver- or
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diumdodecylsulfate Polyacrylamide Gel Electrophoresis) gel.
Immunoblot Analysis. Following SDS-PAGE of the
membranes, the proteins were transferred to poly(vinylidene
difluoride) (PVDF) membranes (Boehringer Mannheim)
using semi dry electroblotting. The blots were analyzed using
monoclonal antibodies directed against a His6 tag (Dianova,
Hamburg, Germany). Antibodies were visualized using the
Western-light chemiluminescence detection kit (Tropix,
Bedford, MA). Expression levels were estimated by deter-
mining the chemiluminescence intensity of each band using
a Lumi-Imager F1 imager (Roche Diagnostics GmbH,
Mannheim, Germany).
Citrate Uptake in RSO Membranes. Uptake of [1,5-14C]-
citrate (114 mCi/mmol, Amersham Pharmacia, The Neth-
erlands) was measured using the rapid filtration method
essentially as described before (2). RSO membranes (final
membrane protein concentration of 0.5 mg/mL) were incu-
bated in 50 mM KPi, pH 6.1, for 2 min at 30 °C with 200
íM phenazine methosulfate (PMS) and 10 mM potassium
ascorbate under a flow of water-saturated air while stirring
magnetically. Initial rates of uptake were determined from
the uptake during the first 10 s at least in duplicate. The
concentration of [1,5-14C]-citrate in the assay was 4.4 íM.
Labeling of Cysteine Residues. RSO membranes were
treated with sulfydryl reactive agents in 50 mM KPi, pH
6.0, at room temperature. ISO vesicles were treated in 50
mM KPi, pH 7.0, also at room temperature. The treatment
was stopped by the addition of an excess of DTT. In substrate
protection experiments, trisodium citrate was added at a 1
mM final concentration 5 min prior to treatment with the
sulfhydryl reagent. Following the treatment, the RSO mem-
branes were washed three times in 50 mM KPi, pH 6.0, to
remove the substrate. Subsequently, the membranes were
resuspended to a protein concentration of 0.5 mg/mL and
assayed for uptake activity. Control samples, without added
substrate and with and without treatment with the thiol
reagent, were treated in the same way. No influence of
residual substrate could be detected indicating that the
washing step was sufficient.
Labeling of whole cells was done essentially as described
by Slotboom et al. (27). In short, cells were resuspended at
a high cell density in 50 mM KPi, pH 6, and stored on ice
until use. After addition of the thiol reagent, one part of the
suspension was sonicated 5 times for 15 s with intermittent
cooling on ice for 45 s, while the other part was kept on ice.
Subsequently, the samples were immediately incubated for
30 min at 37 °C. Unreacted thiol reagent was quenched by
the addition of 1 mM DTT. Membranes were collected by
ultracentrifugation for 20 min at 80 000 rpm at 4°Ci na
Beckman TLA 100.4 rotor followed by partial purification
and labeling with F-5-M as described below.
Partially purified protein was treated with 250 íM
fluorescein-5-maleimide (F-5-M) in 50 mM KPi pH 7.0
containing 0.1% aminoxid. When indicated, labeling was
preceded by treatment with 1 mM N-ethylmaleimide (NEM)
for 15 min at room temperature. The samples were run on a
12% SDS-PAGE gel, and after rinsing the gel with water,
fluorescence was detected using a Lumi-Imager F1 imager
(Roche Diagnostics GmbH, Mannheim, Germany). The gel
was irradiated by UV light, and the emitted light was filtered
with a 520 nM filter. All samples containing F-5-M were
kept in the dark until the gel was exposed. After fluorescence
analysis the gel was CBB stained to estimate protein
concentrations.
Materials. Na (2-sulfonatoethyl) methanethiosulfonate
(MTSES), 2-(trimethylammonium)ethyl methanethiosul-
fonate bromide (MTSET), and 2-ethylammonium methane-
thiosulfonate hydrobromide (MTSEA) were purchased from
Anatrace Inc. (Ohio, USA). NEM was purchased from
Sigma-Aldrich BV (Zwijndrecht, The Netherlands) and
F-5-M and 4-acetamido-4¢-maleimidylstilbene-2,2¢-disulfonic
acid (AMdiS) were purchased from Molecular Probes Europe
BV (Leiden, The Netherlands).
RESULTS
Construction of C-Less CimH. CimH contains two cysteine
residues at positions 231 and 402. C231 is located in the
middle of TMS VI and C402 is located just upstream of the
conserved region in the cytoplasmic loop between TMS X
and TMS XI (Figure 1). Two single cysteine mutants, C231S
and C402S, and the C-less mutant (C231S-C402S) were
constructed. The two single cysteine mutants and the C-less
mutant were expressed to similar levels as the wild-type, as
shown by Western blotting using an antibody directed against
the His tag (Figure 2, inset). Uptake activity in right-side-
out (RSO) membrane vesicles using [1,5-14C]-citrate as the
substrate indicated that all mutants showed 14C-citrate
transport activity (Figure 2). Corrected for expression levels,
the C231S, C402S, and C-less mutants showed specific
activities of 75%, 55%, and 52% relative to wild-type,
respectively.
Treatment of RSO membrane vesicles containing CimH
or one of the mutants with 5 mM of the membrane permeable
thiol reagent N-ethylmaleimide (NEM) for 15 min did not
result in any inhibition of 14C-citrate uptake (data not shown).
The following procedure was followed to show whether the
cysteine residues were actually labeled with NEM. CimH
and the C231S, C402S, and C-less mutants were partially
purified by Ni2+-NTA affinity chromatography and treated
FIGURE 2: Citrate uptake activity of cysteine mutants of CimH.
Proton motive force driven 14C-citrate uptake in RSO membrane
vesicles containing CimH (b), C231S (1), C402S (9), or the C-less
mutant ([). The insert shows the expression levels of the proteins
determined by Western-blotting using an antibody raised against
the His tag.
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fluorescein-5-maleimide (F-5-M). As expected the C-less
mutant did not label, while CimH was readily labeled with
F-5-M (Figure 3A). Labeling of CimH could be completely
prevented by prior incubation of the solubilized protein with
1 mM NEM for 5 min (Figure 3A).
Treatment of the two single cysteine mutants upon
purification with F-5-M resulted in labeling of C231S, but
not of C402S. Apparently, the labeling of the wild-type
reflects labeling of C402 and not of C231. Similar to wild-
type CimH, pretreatment of solubilized C231S with NEM
prevented labeling with F-5-M. In contrast, treatment of the
mutant with NEM prior to purification, i.e., while the protein
was still embedded in the membrane, did not prevent labeling
with F-5-M after purification (Figure 3B).
In conclusion, the C-less version of CimH is functional,
indicating that the two cysteine residues present in CimH
are not essential for citrate transport activity. Furthermore,
the two cysteine residues in the wild-type protein are not
accessible to NEM when the protein is embedded in the
membrane.
Construction and ActiVity of the R143C, R420C, Q428C,
R432C, and R432K Mutants. Mutants R143C, R420C,
Q428C, R432C, and R432K were constructed in both the
wild-type and the C-less genetic background. Unexpectedly,
R420C in the C-less genetic background was not expressed
to levels detectable by Western blotting, and uptake studies
using RSO vesicles showed no 14C-citrate uptake activity
(not shown). All other mutants were expressed to similar
levels in the wild-type and C-less background (see Figure
4, inset).
Uptake activities of the R143C, R420C, and Q428C
mutants in RSO membrane vesicles with 14C-citrate as the
substrate were comparable to wild type (Figure 4). Kine-
tic analysis indicated that the affinity and maximal rates
of uptake of these mutants for the substrates citrate,
L-citramalate and L-malate were not dramatically changed
(Table 1). Apparently, residues R143, R420, and Q428 which
are conserved in the 2HCT family do not play an important
role in the catalytic activity of CimH.
In contrast, replacement of R432 with Cys resulted in the
loss of significant citrate uptake activity (but see below),
while the conservative replacement with Lys severely
reduced the activity to about 5% of the wild type (Figure
4). Kinetic analysis showed that the affinity constant Km of
the R432K mutant for citrate was around 300 íM, which is
1 order of magnitude higher than observed for the wild type.
The maximal rate of transport Vmax was not significantly
altered compared to the wild-type (Table 1). It follows that
the arginine residues at position 432 in the symporter CimH
and at the equivalent position 425 in the citrate/lactate
exchanger CitP are involved in high affinity binding of di/
tricarboxylates in both transporters.
ReactiVity of R143C, R420C, Q428C, and R432C with
NEM. Inside-out (ISO) membrane vesicles containing the
single Cys-mutants R143C, Q428C, and R432C mutants
(C-less background) were treated with NEM, followed by
purification and labeling with F-5-M to assay for the
accessibility of the cysteine residues in the mutants (Figure
5). Mutant R420C was omitted from these experiments since
it does not express in the C-less background. All three
mutants readily labeled with F-5-M in the solubilized state,
and in contrast to the C231S mutant, labeling was prevented
by pretreatment of the ISO membranes with NEM. The
cysteine residues at positions 143, 428 and 432 were labeled
with NEM when CimH was embedded in the membrane.
Treatment of RSO membranes containing R143C with
NEM had no effect on the citrate uptake activity (Figure 4).
A small but significant inhibition was observed for mutant
FIGURE 3: Labeling of the endogenous cysteine residues of CimH
by thiol reactive reagents. (A) Partial purified CimH (lanes 1 and
2), C231S (lanes 3 and 4), C402S (lanes 5 and 6), and C-less (lanes
7 and 8) was treated with F-5-M with or without prior treatment
with 1mM NEM for 5 min as indicated. (B) ISO membranes
containing the C231 mutant were or were not treated with 1 mM
NEM for 15 min as indicated, followed by partial purification and
treatment with F-5-M. The upper lanes show the fluorescence image
of the gel and the lower lanes the protein content after CBB staining.
The marker proteins shown in the most left lane in panel A represent
proteins of 50 and 37 kDa.
FIGURE 4: Effect of N-ethylmaleimide on citrate uptake activity
catalyzed by cysteine mutants. Initial rate of 14C-citrate uptake in
RSO vesicles containing the indicated CimH alleles before (closed
bars) and after (open bars) treatment with 5 mM NEM for 10 min.
The rates were expressed as the percentage of the initial rate of the
untreated wild-type CimH. The insert shows the expression levels
of the proteins determined by Western blotting.
Table 1: Kinetic Analysis of 14C-Citrate Uptake Catalyzed by
Wild-Type and Mutant CimH Transporters
citrate L-malate L-citramalate
Vmax(nmol
min-1 mg-1)
Km
(íM)
KI
a
(íM)
KI
a
(íM)
wild type 37 10 1.5 100
R143C 50 10 1 100
R420C 36 14 1 55
Q428C 33 12.5 2 35
R432K 31 300 ndb ndb
a Inhibition constants determined from the inhibition of the initial
rate of citrate uptake. b Not determined.
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residue at position 420 is accessible to NEM. The most
severe effect of NEM labeling was observed for the Q428C
mutant that was almost completely inactivated. The different
effects on the R420C and Q428C mutants were due to
different kinetics of labeling (Figure 6). The Q428C mutant
labeled with NEM with a half time of about 3-4 min, while
under identical conditions, the R420C mutant retained about
50% residual activity after 15 min of treatment. Prolonged
incubation of the R420C eventually completely inhibited
citrate transport (data not shown).
It is concluded that labeling of a cysteine at position 143
in CimH leaves the activity of the protein unaltered, while
labeling of cysteines at positions 420 and 428 completely
inhibit the protein. The reactivity of the cysteine residue in
R420C was significantly lower than observed for the cysteine
in Q428C. Furthermore, the cysteine in the inactive mutant
R432C was shown to be accessible to NEM.
ReactiVation of R432C with MTS Reagents. The meth-
anethiosulfonate (MTS) derivatives MTSEA, MTSET, and
MTSES represent a set of thiol reactive reagents that differ
in size and charge of the groups attached to the reactive MTS
moiety. They react with cysteine residues on proteins to form
disulfides, thereby introducing a positive (MTSEA, MTSET)
or negative (MTSES) charge on the protein at the site of the
cysteine residue (17, 18). RSO vesicles containing the
inactive R432C mutant were incubated for 15 min with 1
mM of each of the three reagents (Figure 7). A very low
uptake activity of about 0.5% of the wild-type activity was
observed in the untreated membranes suggesting that the
R432C is not completely inactive. When R432C was treated
with MTSES (negative), the initial uptake rate was decreased
by a factor of 2. The positively charged MTSET had no
effect, but treatment with MTSEA which is less bulky than
MTSET resulted in an increase of activity of about a factor
of 2 (Figure 7). Since the uptake activities in these experi-
ments were very low, the uptake of citrate was measured in
triplicate after 1 min of incubation. The results justified the
conclusion (Figure 7, insert) that the positive charge of
MTSEA linked to the cysteine introduced at position 432
reactivated the mutant, while the negative charge of MTSES
further lowered the activity. The activation of the R432C
mutant by the MTSEA reagent is in line with the activity
observed for the R432K mutant and suggests that a positive
charge at position 432 improves substrate binding.
Accessibility of R420C and Q428C. Depending on their
variable group, MTS reagents are either membrane permeable
(MTSEA) or impermeable (MTSES, MTSET). The acces-
sibility of the cysteine residues at positions 420 and 428 in
the C-terminal cytoplasmic loop for the reagents was
investigated in RSO membrane vesicles. Both the wild-type
CimH protein and the R143C mutant were not inhibited by
treatment with any of the MTS reagents (not shown). The
R420C mutant in the wild type background showed severe
inhibition when treated with MTSES and MTSEA, but not
with MTSET (Figure 8, left). The effect of MTSES
(impermeable) was more pronounced than the effect of
MTSEA (permeable). Similarly, the single-Cys mutant
Q428C was inhibited by both MTSES and MTSEA and not
FIGURE 5: Accessibility of cysteines to thiol reactive reagents. ISO
vesicles expressing R143C (lanes 1 and 2), Q428C (lanes 3 and
4), and R432C (lanes 5 and 6) were treated with and without 1
mM NEM for 15 min as indicated, followed by partial purification
and treatment with F-5-M. The upper lanes show the fluorescence
image of the part of the gel containing the CimH mutants. The
lower lanes show the same part of the gel after staining for protein
with CBB.
FIGURE 6: Kinetics of NEM labeling. RSO vesicles containing
CimH (b), R420C (9) or Q428C (2) were incubated for increasing
periods of time with 5 mM NEM after which 14C-citrate uptake
activity was determined. The remaining activity was plotted relative
to the activity of the untreated membranes.
FIGURE 7: Reactivation of R432C with MTS reagents. 14C-citrate
uptake activity was measured in RSO membranes containing the
R432C mutant without any treatment (b) or after treatment with
MTSET (9), MTSES (1), and MTSEA ([) at 1 mM concentra-
tions. (inset) The uptake was measured at t ) 1 min in triplicate
for the same conditions. Bars and error bars represent the average
uptake levels and standard deviations, respectively.
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experiments the MTS reagent were used at the same
concentration of 1 mM, while the reactivity of the reagents
decreases in the order of MTSET > MTSEA > MTSES (17).
The results suggest that the cysteine residues of both R420C
and Q428C are accessible in RSO membranes to the
membrane impermeable, negatively charged MTSES reagent.
AMdiS is a membrane impermeable, negatively charged
maleimide based thiol reagent that is more bulky than
MTSES (MW of 536 and 219 Da, respectively. In contrast
to MTSES, treatment of RSO membranes containing Q428C
(C-less background) with AMdiS did not effect the activity
of the mutant (not shown). Treatment of whole cells
expressing the Q428C mutant with AMdiS followed by
partial purification and labeling with F-5-M showed that the
lack of inactivation by AMdiS was due to lack of reaction
with the reagent (Figure 9). In the same experiment, MTSES
did prevent labeling with F-5-M. Importantly, sonication of
the cells in the presence of AMdiS also prevented subsequent
labeling with F-5-M showing that the C428 residue was
accessible for AMdiS, but only from the cytoplasmic side
of the membrane.
The inactivation of mutants R420C and Q428C by the thiol
reactive reagents NEM, MTSEA and MTSES was studied
in the presence of substrate (Figure 8). Labeling of R420C
with the reagents was completely prevented by the presence
of 1 mM of citrate during the treatment. In case of R428C,
MTSES labeling was largely prevented in the presence of
the same concentration of citrate, but labeling with NEM
and MTSEA, both of which are membrane permeable, was
not influenced. The results suggest that in the presence of
citrate, R420C is no longer accessible from either side of
the membrane while in the case of Q428C substrate blocks
the accessibility from the outside, but not from the inside.
DISCUSSION
Members of the 2HCT family recognize substrates that
contain a 2-hydroxycarboxylate motif. Binding of the
substrates is mediated by essential interactions between sites
on the protein and the hydroxyl and carboxylate groups of
the motif. The hydroxyl group was speculated to form
hydrogen bonds with the protein (5), while the carboxylate
is likely to interact via electrostatic interactions in combina-
tion with hydrogen bonding. In search for the sites on the
proteins that interact with the 2-hydroxycarboxylate motif,
we mutated four conserved residues in CimH of B. subtilis,
R143, R420, Q428, and R432, that are positively charged
and/or capable of forming hydrogen bonds. Mutation of
R143, R420, and Q428 to Cys did not affect the kinetic
parameters of the transporter, indicating that none of these
residues are essential for transport activity. Substitution of
R432 for a cysteine residue greatly reduced citrate transport
activity, which was in line with previous results obtained
for the same mutation of R425, the corresponding residue
of R432 in CitP of Lc. mesenteroides. R425 in CitP was
shown to be responsible for the nonessential interaction with
the carboxylate group at the RS position in di/tricarboxylates
(see below; 14). The results for the R143 and R420 mutations
were unexpected since the two arginine residues are the only
conserved positive charges (in addition to R432) in the 2HCT
family, which to date contains 10 different proteins. Possibly,
electrostatic interactions are not involved in the binding of
the carboxylate group of the 2-hydroxycarboxylate motif,
or the group interacts with residues that are not conserved.
The 2HCT family contains H+ or Na+ symporters and
exchangers that couple the uptake of the substrate to the exit
of a structurally related metabolic end product of the
FIGURE 8: Substrate protection against inactivation by thiol reactive reagents. RSO membranes containing the R420 (left) and Q428 (right)
mutants were treated with the indicated thiol reagents in the presence (open bars) and absence (closed bars) of 1 mM citrate. The R420C
mutant was treated with 10 mM NEM for 15 min and the Q428 mutant with 5 mM NEM for the same period of time. The concentration
of the MTS reagents was 1 mM. Activity was plotted as the percentage of the activity of untreated membranes.
FIGURE 9: Accessibility of Q428C in whole cells to AMdiS and
MTSES. E. coli strain TOP10 expressing the Q428C mutant was
treated with 0.5 mM AMdiS with and without sonication as
indicated and 1 mM MTSES without sonication (see Methods).
The upper lanes show the fluorescence image, the lower lanes the
protein stained gel. The lane on the right shows two marker proteins.
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group and exchanges citrate for L-lactate. The affinity of CitP
for the tricarboxylate citrate is 3 orders of magnitude higher
than that for the monocarboxylate lactate. It was demon-
strated that R425 of CitP is responsible for the high-affinity
binding of citrate by interacting directly with the carboxylate
at the RS position (Figure 1), which is absent in L-lactate
(14). R425 of CitP is conserved throughout the 2HCT family
and corresponds to R432 of CimH, which belongs to the
symporters in the family. CimH only transports substrates
containing a carboxylate group at the RS position, i.e., citrate,
L-malate, and L-citramalate, and it was anticipated that the
interaction of R432 of CimH with the substrates would be
more critical than in the case of R425 of CitP (2). Neverthe-
less, the properties of the R432 mutants of CimH suggest a
similar role in substrate binding. In both transporters,
replacement of the arginine residue with Cys reduced
transport activity by 2 orders of magnitude. The conservative
arginine to lysine mutation resulted in a lowering of the
affinity for the substrate by 2 orders of magnitude. Remark-
ably, the maximal rate of the R432K mutant of CimH was
unchanged, while the R425K mutant of CitP showed a
strongly reduced maximal rate. It should be noted though
that the kinetic modes were different, unidirectional uptake
and exchange, respectively. Positioning of a positive charge
at the cysteine residues in the arginine-to-cysteine mutants
of the transporters via labeling with MTSEA enhanced
transport activity 2-fold and 48-fold for CimH and CitP,
respectively. In contrast, introducing a negative charge by
labeling with MTSES reduced transport 2-fold in both
transporters. Apparently, the interaction between the con-
served arginine and the carboxylate group at the RS position
of the substrates is not responsible for the lack of binding
of L-lactate by CimH. The most prominent difference
between R432 in CimH and R425 in CitP is the accessibility
of the site from the outside of the cell. Using membrane-
permeable and -impermeable thiol reagents, it was concluded
that R425 in CitP was not accessible from the outside (14),
while in this study it is concluded that R432 in CimH is
accessible from the outside (see below). This difference may
reflect the different physiological functions of symport and
exchange of the transporters in the family.
Wild-type CimH and the single-Cys mutants were treated
with thiol reactive reagents both in the detergent solubilized
state and in the membrane embedded state. Three different
labeling behaviors were observed. (i) Cysteine residues at
positions 143, 420, 428, and 432 were readily labeled both
in the detergent solubilized and in the membrane embedded
state, indicating that the residues are exposed to the aqueous
phase in both states. (ii) The cysteine at position 231, located
in the middle of TMS VI, was not labeled with F-5-M in
either state. F-5-M is believed to react with thiols in a
hydrophilic environment, but has also been reported to be
able to penetrate into lipophilic environments and react with
cysteine residues within a detergent micel (19, 20). The
complete lack of reactivity of C231 suggests that this position
is buried in the protein structure. (iii). The cysteine at position
402 is readily labeled when solubilized in detergent but not
when embedded in the membrane. The latter observation is
in agreement with data obtained for CitS of K. pneumoniae
showing that the cysteine residue at the corresponding
position was not accessible to the thiol reagents AMdiS and
3-(N-maleimido-propinyl) biocytin (MBP) in everted mem-
brane vesicles, nor in whole cells (21). Possibly, the
transporters are present in a higher oligomeric state in the
membrane (22, 23), in which the cysteine at position 402
(CimH numbering) is shielded. In the detergent solubilized
state, the oligomeric state may be lost, thereby exposing C402
to the water phase. Alternatively, local conformational
changes or increased flexibility upon solubilization may be
responsible for the observed labeling in detergent solution.
Cysteine residues at positions 420 and 428 in a putative
cytoplasmic loop of CimH reacted with the membrane
impermeable MTSES reagent in right-side-out membrane
vesicles, indicating that the residues are accessible through
the protein from the exterior side of the cell membrane. The
access pathway is likely to be the substrate translocation
pathway since, (i) positions 420 and 428 are close to R432
that interacts directly with the substrate, (ii) labeling of the
cysteines at positions 420 and 428 resulted in an inactive
transporter, and (iii) substrate binding protected against
inactivation. The membrane permeable thiol reagent NEM
reacted considerably faster with Q428C than with R420C.
NEM was found to react much faster with water accessible
cysteines than with cysteines in the lipid phase (24),
suggesting that R420C is only poorly accessible from the
water phase. Surprisingly, membrane impermeable MTSES,
which is believed to react only from the water phase, reacted
faster with R420C than NEM. Moreover, at the same
concentrations, MTSES reacted faster with R420C than the
positively charged MTS derivatives MTSEA and MTSET,
the latter of which was not reactive at all. The difference is
not caused by differences in reactivity, as MTSES is about
4 times less reactive than MTSEA and 10 times less than
MTSET (17). It is tempting to explain the different labeling
kinetics by assuming that the entrance pathway for the
substrate from the outside in CimH would be optimized for
negatively charged substrates such as citrate and malate.
The translocation pathway would favor negatively charged
MTSES over the positively charged MTSEA and MTSET,
and neutral NEM to penetrate to R420C. Possibly, membrane-
permeable MTSEA and NEM react with R420C (and
Q428C) from the inside, which would explain why membrane-
impermeable MTSET does not react at all. Interestingly,
molecular modeling studies have shown that MTSES and
citrate have very similar molecular volumes and it was
suggested that negatively charged MTSES might be a
substrate analogue (25). The inaccessibility of C428 in the
Q428C mutant for the negatively charged, but more bulky
reagent AMdiS supports this hypothesis.
Labeling of the R420C mutant was prevented by the
presence of substrate, irrespective of the nature of the thiol
reactant, suggesting that R420 is close to the substrate in
the three-dimensional structure of CimH. In contrast, sub-
strate protected the Q428C mutant against labeling by
membrane impermeable MTSES and not against membrane
permeable MTSEA and NEM, suggesting that the substrate
blocks the access pathway to C428 from the outside and not
from the inside (Figure 10).
Similar results as those reported here were obtained for
residues in a cytoplasmic loop of the related glutamate
transporters GltT of B. stearothermophilus and GLT-1, found
in the central nervous system (26, 27). It was concluded that
the cytoplasmic loop in part traverses the membrane and
Binding Site of Citrate/Malate Transporter CimH Biochemistry, Vol. 42, No. 2, 2003 473forms a reentrant loopike structure as commonly observed
in channels (28). Possibly, the cytoplasmic loop between
TMS X and XI in the transporters of the 2HCT family is
folded in a similar structure. A more systematic Cys scanning
of this region in CimH is necessary to confirm this
hypothesis.
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FIGURE 10: Model for the membrane topology of the C-terminal
region of CimH. The two boxes represent putative transmembrane
segments X and XI. The putative location of the substrate relative
to the residues substituted with cysteine is indicated in gray. The
top of the scheme is the periplasmic side of the protein.
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